BCR activation of SLL/CLL cells can increase the level of the anti-apoptotic protein MCL-1 and subsequent resistance to fludarabine, or induce down-regulation of MCL-1 and induction of apoptosis, depending on the nature of BCR stimulation[29] . This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.